Biotech Stock Roundup: CRL for REGN, GILD’s Drug Approval, LQDA Down on News
ZacksBigwigs Regeneron (REGN) and Gilead Sciences (GILD) are in the spotlight following regulatory updates and drug approval, respectively.
Bigwigs Regeneron (REGN) and Gilead Sciences (GILD) are in the spotlight following regulatory updates and drug approval, respectively.